Search
for
Sort by
Research 61–90 of 1000+
- Cyproterone Acetate: A Genotoxic Carcinogen?
- CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?
- Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
- Germacrene Analogs are Anti-androgenic on Androgen-dependent Cells
- Squamous metaplasia of the prostate and diffuse alopecia in a 13-year-old castrated dog due to chronic ingestion of exogenous estradiol
- Role of 5 alpha-reductase inhibitors in the management of prostate cancer
- Anti-Androgen Effects of Extracts and Compounds from<i>Ganoderma lucidum</i>
- Male pattern baldness and incidence of prostate cancer
- Synthesis and activity of 8-substituted benzo[c]quinolizin-3-ones as dual inhibitors of human 5α-reductases 1 and 2
- Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment
- Protective role of agomelatine via modulation of TLR4/NF-κB: NLRP3/IL-1β signaling pathways in testosterone-induced benign prostatic hyperplasia in rats
- S2 PSA: RELIABLE OR NOT RELIABLE?
- Activated Polyamine Catabolism Depletes Acetyl-CoA Pools and Suppresses Prostate Tumor Growth in TRAMP Mice
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Androgenetic Alopecia and Risks of Overall and Aggressive Prostate Cancer: An Updated Systematic Review and Meta-Analysis
- Factors Driving Unique Urination Phenotypes of Male and Female 9-week-old C57BL/6J Mice
- Steroidogenesis in steroid related cancers
- ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer
- Intermittent Use of Testosterone Inactivating Pharmaceuticals Using Finasteride Prolongs the Time Off Period
- Differential expression of steroid 5α-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer
- The Percentage of Free PSA and Urinary Markers Distinguish Prostate Cancer from Benign Hyperplasia and Contribute to a More Accurate Indication for Prostate Biopsy
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- Prostate Cancer Early Detection, Version 2.2015
- Ganoderma lucidum is an inhibitor of testosterone-induced prostatic hyperplasia in rats
- Potential adverse effects of long-term testosterone therapy
- Significance of the polyglutamine tract polymorphism in the androgen receptor
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model
- 5α-Reduced glucocorticoids: a story of natural selection
- Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase